Hanne Leth Hillman
Chairman at The Danish Investor Relations Society
Profile
Hanne Leth Hillman is currently the Co-Chairman at The Danish Investor Relations Society and the Chief Financial Officer at Nanovi Radiotherapy A.
Previously, she held positions such as VP, Director-Investor Relations & Capital Market at NTG Nordic Transport Group A in 2009-2010, Analyst at Gudme Raaschou Bank A in 2004, and Senior VP-Investor Relations & Communications at Zealand Pharma A in 2015-2016.
Ms. Hillman obtained an MBA from the University of Aarhus.
Hanne Leth Hillman active positions
| Companies | Position | Start |
|---|---|---|
| The Danish Investor Relations Society | Chairman | - |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Director of Finance/CFO | 2017-04-30 |
Former positions of Hanne Leth Hillman
| Companies | Position | End |
|---|---|---|
| BRAIN+ A/S | Director of Finance/CFO | 2023-12-31 |
| ZEALAND PHARMA A/S | Investor Relations Contact | 2016-09-30 |
| Gudme Raaschou Bank A/S | Analyst-Equity | 2004-11-04 |
| NTG NORDIC TRANSPORT GROUP A/S | Investor Relations Contact | - |
Training of Hanne Leth Hillman
| University of Aarhus | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| BRAIN+ A/S | Technology Services |
| Private companies | 3 |
|---|---|
| The Danish Investor Relations Society | |
| Gudme Raaschou Bank A/S | Finance |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
- Stock Market
- Insiders
- Hanne Leth Hillman